Clinical Trials

Ventracor Limited Investor Update March 2007

🕔3/29/2007 10:54:01 AM

We are pleased and proud that the VentrAssist is an Australian success story that has improved the lives of almost 100 patients world-wide. The VentrAssist is still the only centrifugal LVAD and the only third generation LVAD in clinical trials in the USA. There is more world-wide clinical experience with the VentrAssist than all centrifugal LVADs from all competitors, combined.

Read Full Article

Ventracor announced completion of field exchange of all VentrAssist controllers

🕔9/28/2005 4:59:05 PM

Ventracor Chief Executive Officer Colin Sutton PhD said: "All patients in the US, Europe and Australia have had their controllers exchanged without incident."

Read Full Article